Market-Moving News for June 17th
Market-Moving News for June 17th
6月17日市場資訊
BBY: 4% | UBS Upgrades Best Buy Co to Buy, Raises Price Target to $106
百思買：4% | 瑞銀將百思買評級升至買入，將價格目標提高至106美元
ZYME: 13% | Zymeworks shares are trading higher after the FDA cleared the company's Investigational New Drug application for Zw171 for mesothelin-expressing cancers, with the company expecting to initiate clinical development during 2024.
zymeworks：13% | 經FDA審核後，Zymeworks公司的針對表達介質爲mesothelin的腫瘤的新藥Investigational New Drug已獲批准，公司計劃在2024年開始臨床試驗
QTTB: 9% | Q32 Bio shares are trading higher after Guggenheim initiated coverage with a Buy rating and a $100 price target.
Q32 Bio：9% | Q32 Bio股票在Guggenheim的買入評級和100美元的價格目標下交易較高
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。